Ana Antun
- Department of Hematology and Medical Oncology
Associate Professor
- (404) 778-1900
- ana.antun@emoryhealthcare.org
Academic Appointment
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from National University of Cordoba
Research
Focus
- My research focuses on drug discovery and quality of life improvement for bleeding and thrombotic disorders, and especially for both end of the spectrum of platelet disorders; thrombotic thrombocytopenic purpura and thrombocytopenic patients with hematological malignancies. I am conducting clinical studies to understand the relationship between hemophilia, arthropathy and reduction of functional ability, and the association between obesity, severity of hemophilia and bone density.
Publications
-
Global patterns of hemophilia drug trials, hemophilia care, and health care measures.
Res Pract Thromb Haemost Volume: 9 Page(s): 102714
02/01/2025 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Gillespie TW; Buckner TW; Tran DQ; Antun A; Kempton CL -
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.
Blood Adv Volume: 9 Page(s): 417 - 424
01/28/2025 Authors: Fatola A; Evans MD; Brown J; Davis E; Johnson A; Antun AG; Farland AM; Woods R; Metjian A; Park YA -
Women and girls' participation in haemophilia clinical trials.
Haemophilia Volume: 30 Page(s): 1440 - 1443
11/01/2024 Authors: Fedewa SA; Cafuir L; Valentino LA; Koo A; Antun A; Kempton CL -
Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome.
Blood Volume: 144 Page(s): 1143 - 1152
09/12/2024 Authors: Cataland SR; Coppo P; Scully M; Lmmle B -
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia.
J Racial Ethn Health Disparities Volume: 11 Page(s): 1394 - 1404
06/01/2024 Authors: Fedewa SA; Buckner TW; Parks SG; Tran DQ; Cafuir L; Antun AG; Mattis S; Kempton CL -
Race and ethnicity reporting and representation in hemophilia clinical trials.
Blood Adv Volume: 8 Page(s): 2351 - 2360
05/28/2024 Authors: Fedewa SA; Valentino LA; Koo A; Cafuir L; Tran DQ; Antun A; Kempton CL -
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
N Engl J Med Volume: 390 Page(s): 1584 - 1596
05/02/2024 Authors: Scully M; Antun A; Cataland SR; Coppo P; Dossier C; Biebuyck N; Hassenpflug W-A; Kentouche K; Knbl P; Kremer Hovinga JA -
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.
Res Pract Thromb Haemost Volume: 8 Page(s): 102388
03/01/2024 Authors: Abou-Ismail MY; Zhang C; Presson AP; Chaturvedi S; Antun AG; Farland AM; Woods R; Metjian A; Park YA; de Ridder G -
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
Blood Adv Volume: 8 Page(s): 620 - 623
02/13/2024 Authors: Abou-Ismail MY; Zhang C; Presson AP; Chaturvedi S; Antun AG; Farland AM; Woods R; Metjian A; Park YA; de Ridder G -
Racial and ethnic differences in reported haemophilia death rates in the United States.
Haemophilia Volume: 29 Page(s): 1410 - 1418
11/01/2023 Authors: Fedewa SA; Payne AB; Tran D; Cafuir L; Antun A; Kempton CL